[Fire Fighting] Extinguish with carbon dioxide, dry chemical powder or appropriate foam. Water spray. Wear self-contained breathing apparatus and protective clothing to prevent contact with the skin and eyes. | |
[Storage] Store in original container in a cool dark place. | |
[Inhalation] Remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. Seek medical attention. | |
[Skin] Immediately wash skin with soap and copious amounts of water for at least 15 minutes. If irritation persists, seek medical attention. | |
[Eyes] Immediately flush eyes with copious amounts of water for at least 15 minutes. Seek medical advice. | |
[Ingestion] If swallowed, wash out mouth with water, provided person is conscious. Seek medical advice. | |
[Personal Protection] Wear self-contained breathing apparatus, rubber boots & heavy rubber gloves. | |
[Solubility in water] (nsoluble | |
[Melting Point] 40 -41 | |
[Vapor Pressure] 4.2E-15 (25 C) | |
[Density] 0.976 g/cm3 (20 C) | |
[pKa/pKb] 14.59 (pKa) | |
[Partition Coefficient] 8.95 | |
[Usage] A drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet. | |
[Product Name] (-)-Tetrahydrolipstatin | |
[Synonyms] (-)-Tetrahydrolipstatin L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester | |
[CAS] "CASEN_96829-58-2.htm">96829-58-2 | |
[Formula] C29H53NO5 | |
[Molecular Weight] 495.74 | |
[Merck] 12,6997 | |
[Small spills/leaks] Sweep-up/absorb in suitable material, place in a container and hold for disposal. Avoid raising dust. Ventilate area and wash spill site after pickup is complete. | |
[Combustion Products] Emits toxic fumes under fire conditions. |